ArticleBlood neoplasia2025
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study.
Priyanka Pullarkat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it